The Stockholm Pilot study for Lung cancer Screening (Stockholm PLUS): feasibility of baseline low-dose CT lung cancer screening in a high-risk Swedish female population
DOI:
https://doi.org/10.2340/1651-226X.2026.44826Keywords:
Lung Neoplasm, Mass Screening, Low-Dose Computed Tomography, Early Detection of Cancer, Smoking, Artificial IntelligenceAbstract
Background and purpose: Low-dose CT screening of high-risk groups has been shown to reduce lung cancer mortality, and the European Council has therefore recommended that member states explore the feasibility and effectiveness of this approach. In this study, we evaluate the implementation of low-dose CT screening for lung cancer in a Swedish female population.
Patient/material and methods: Women aged 54–74 years in the Southern Stockholm region were contacted via an electronic questionnaire. Individuals who met the same eligibility criteria as in the NELSON trial (a minimum smoking history of 15 pack-years) were invited. The screening consisted of a baseline low-dose computed tomography (LDCT) scan, with the option for a follow-up scan in cases with intermediate findings. Findings were managed in accordance with modified Fleischner Society guidelines.
Results: Between September 2022 and September 2024, 34,580 invitation letters were sent to randomly selected women aged 54–74 years 11,607 individuals (33.4%) completed the questionnaire, whereof 1,106 (10%) met the inclusion criteria. 990 (90%) individuals accepted the invitation and underwent a baseline low-dose CT scan. There were 152 intermediate and 55 positive scans at baseline, and additional eight positive scans at follow-up. Fifteen cases of Lung cancer were found, yielding a positive prediction value (PPV) of 24%. 87% of the lung cancers were in stage IA.
Interpretation: Organized lung cancer screening in a Swedish female population proved feasible, demonstrating a good participation rate, and a cancer detection rate consistent with findings from other major screening trials.
Downloads
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3): 209–249.
https://doi.org/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660
de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am. 2012;50: 863–876.
https://doi.org/10.1016/j.rcl.2012.06.006 DOI: https://doi.org/10.1016/j.rcl.2012.06.006
Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3): 889–902.
https://doi.org/10.1183/13993003.00359-2016 DOI: https://doi.org/10.1183/13993003.00359-2016
Remon J, Soria JC, Peters S. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol. 2021;32:1637–1642.
https://doi.org/10.1016/j.annonc.2021.08.1994 DOI: https://doi.org/10.1016/j.annonc.2021.08.1994
Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, et al. The International Association for the study of lung cancer lung cancer staging project: proposals for revision of the TNM Stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2024;19(7):1007–1027.
https://doi.org/10.1016/j.jtho.2024.02.011 DOI: https://doi.org/10.1016/j.jtho.2024.02.011
Adams SJ, Stone E, Baldwin DR, Vliegenthart R, Lee P, Fintelmann FJ. Lung cancer screening. Lancet. 2023;401:390–408.
https://doi.org/10.1016/S0140-6736(22)01694-4 DOI: https://doi.org/10.1016/S0140-6736(22)01694-4
Aberle D, Adams. A, Berg c, Black W, ClappJ, Fagerstrom R, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):390–408.
https://doi.org/10.1056/NEJMoa1102873 DOI: https://doi.org/10.1056/NEJMoa1102873
Horeweg N, Van Der Aalst CM, Thunnissen E, Nackaerts K, Weenink C, Groen HJM, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med. 2013;187(8):848–854.
https://doi.org/10.1164/rccm.201209-1651OC DOI: https://doi.org/10.1164/rccm.201209-1651OC
de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–513.
https://doi.org/10.1056/NEJMoa1911793 DOI: https://doi.org/10.1056/NEJMoa1911793
Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Screening for lung cancer: US preventive services task force recommendation statement. JAMA. 2021;325(10)962–970.
https://doi.org/10.1001/jama.2021.1117 DOI: https://doi.org/10.1001/jama.2021.1117
Moyer VA. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;160(5):330–338.
https://doi.org/10.7326/M13-2771 DOI: https://doi.org/10.7326/M13-2771
Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, et al. European position statement on lung cancer screening. Lancet Oncol. 2017;18(12):e754–e766.
https://doi.org/10.1016/S1470-2045(17)30861-6 DOI: https://doi.org/10.1016/S1470-2045(17)30861-6
Sasieni P, Baldwin D, Barnard S, Booton R, Callister M, Crosbie P et al. NHS. Targeted screening for lung cancer with low radiation dose computed tomography Standard protocol prepared for the Lung Cancer Screening Programme- Publication reference: PR1646. 2025. [cited 2024-08-02] Available from: https://www.england.nhs.uk/wp-content/uploads/2019/02/2502-B1646-standard-protocol-prepared-for-the-lung-cancer-screening-programme.pdf
Australian Government Department of Health and Aged Care. National Lung Cancer Screening Program (2024). Australian Government Department of Health and Aged Care; 2024. Available from https://www.health.gov.au/sites/default/files/2026-01/national-lung-cancer-screening-program-healthcare-provider-presentation.pdf
Vogel-Claussen J, Blum TG, Andreas S, Bauer TT, Barkhausen J, Harth V, et al. Statement paper on the implementation of a national organized program in Germany for the early detection of lung cancer in risk populations using low-dose CT screening including management of screening findings. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2024;196(2): 134–153.
Zhang Y, Chen H. Lung cancer screening: who pays? Who receives? – the Chinese perspective. Transl Lung Cancer Res. 2021;10: 2389–2394.
https://doi.org/10.21037/tlcr.2020.03.16 DOI: https://doi.org/10.21037/tlcr.2020.03.16
PDF european Commission. Press release European Health Union: IP/22/7548. Available from https://ec.europa.eu/commission/presscorner/api/files/document/print/en/ip_22_5562/IP_22_5562_EN.pdf. Author name: Stella Kyriakides, City: Bruxelle.
Kauczor HU, von Stackelberg O, Nischwitz E, Chorostowska-Wynimko J, Hierath M, Mathonier C, et al. Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium. Insights Imaging. 2024;15(1):252.
https://doi.org/10.1186/s13244-024-01814-5 DOI: https://doi.org/10.1186/s13244-024-01814-5
Pedersen JH, Sørensen JB, Saghir Z, Fløtten Ø, Brustugun OT, Ashraf H, et al. Implementation of lung cancer CT screening in the Nordic countries. Acta Oncol. 2017;56: 1249–1257.
https://doi.org/10.1080/0284186X.2017.1329592 DOI: https://doi.org/10.1080/0284186X.2017.1329592
Wichmann V, Iivanainen S, Mattila L, Kokkonen VP, Jartti A, Kurtti A, et al. Lung cancer screening in Finland: a prospective randomized trial. Acta Oncol (Madr). 2025;64:769–774.
https://doi.org/10.2340/1651-226X.2025.43093 DOI: https://doi.org/10.2340/1651-226X.2025.43093
Revel MP, Chassagnon G. Ten reasons to screen women at risk of lung cancer. Insights Imaging. 2023;14(1)176.
https://doi.org/10.1186/s13244-023-01512-8 DOI: https://doi.org/10.1186/s13244-023-01512-8
Carioli G, Malvezzi M, Bertuccio P, Boffetta P, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. Ann Oncol. 2021;32(4):478–487.
https://doi.org/10.1016/j.annonc.2021.01.006 DOI: https://doi.org/10.1016/j.annonc.2021.01.006
Fridhammar A. IHE-Rapport-2020_5_. Institutet för Hälso- och Sjukvårdsekonomi; 2020. Available from https://ihe.se/app/uploads/2020/10/IHE-Rapport-2020_5_.pdf
Tammemägi MC, Hormuzd AK, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368(8):728–36. DOI: https://doi.org/10.1056/NEJMoa1211776
Becker N, Motsch E, Trotter A, Heussel CP, Dienemann H, Schnabel PA, et al. Lung cancer mortality reduction by LDCT screening – results from the randomized German LUSI trial. Int J Cancer. 2020;146(6):1503–1513.
https://doi.org/10.1002/ijc.32486 DOI: https://doi.org/10.1002/ijc.32486
Quaife SL, Ruparel M, Beeken RJ, McEwen A, Isitt J, Nolan G, et al. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients. BMC Cancer. 2016;16(1):281.
https://doi.org/10.1186/s12885-016-2316-z DOI: https://doi.org/10.1186/s12885-016-2316-z
Dickson JL, Hall H, Horst C, Tisi S, Verghese P, Mullin AM, et al. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study. Lancet Public Health. 2023;8(2):e130–e140.
https://doi.org/10.1016/S2468-2667(22)00258-4 DOI: https://doi.org/10.1016/S2468-2667(22)00258-4
Crosbie PAJ, Gabe R, Simmonds I, Kennedy M, Rogerson S, Ahmed N, et al. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk. BMJ Open. 2020;10(9):e037075.
https://doi.org/10.1136/bmjopen-2020-037075 DOI: https://doi.org/10.1136/bmjopen-2020-037075
Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, et al. The UK lung cancer screening trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess (Rockv). 2016;20(40):1–146.
https://doi.org/10.3310/hta20400 DOI: https://doi.org/10.3310/hta20400
Stenger M. Lung cancer screening in Denmark. In: Nordic Lung cancer symposium – 2025. 2025. Available from https://cancerakademin.se/evenemang/nordic-lungcancer-symposium-2025/
Stenger M. Project Lung Cancer Screening in Southern Denmark (PLUS). [cited 2024-08-02] Available from: https://clinicaltrials.gov/study/NCT06537804
Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;21(3):308–315.
https://doi.org/10.1097/CEJ.0b013e328351e1b6 DOI: https://doi.org/10.1097/CEJ.0b013e328351e1b6
MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017;284:228–243.
https://doi.org/10.1148/radiol.2017161659 DOI: https://doi.org/10.1148/radiol.2017161659
Baldwin DR, Callister MEJ. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax. 2015;70(8):794–798.
https://doi.org/10.1136/thoraxjnl-2015-207221 DOI: https://doi.org/10.1136/thoraxjnl-2015-207221
Henschke CI, Yip R, Shaham D, Markowitz S, Deval JC, Zulueta JJ, et al. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Radiology. 2023;309(2):e231988.
El Alam R, Byrne SC, Hammer MM. Rate of benign nodule resection in a lung cancer screening program. Clin Imaging. 2023;104:109984–109995.
https://doi.org/10.1016/j.clinimag.2023.109984 DOI: https://doi.org/10.1016/j.clinimag.2023.109984
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Oscar Grundberg, Paulina Kalinowska, Pierre Hillegren, Nicolas Peyrard Janvid, Axel Dimberg, Nina Markholm Nordgren, Fredrik Strand, Vitali Grozman, Gunnar Wagenius
This work is licensed under a Creative Commons Attribution 4.0 International License.
